Dolphin Multiple Cross Site Scripting Vulnerabilities
BID:46337
Info
Dolphin Multiple Cross Site Scripting Vulnerabilities
| Bugtraq ID: | 46337 |
| Class: | Input Validation Error |
| CVE: | |
| Remote: | Yes |
| Local: | No |
| Published: | Feb 10 2011 12:00AM |
| Updated: | Feb 10 2011 12:00AM |
| Credit: | AutoSec Tools |
| Vulnerable: |
Boonex Dolphin 7.0.4 |
| Not Vulnerable: | |
Discussion
Dolphin Multiple Cross Site Scripting Vulnerabilities
Dolphin is prone to multiple cross-site scripting vulnerabilities because it fails to properly sanitize user-supplied input.
An attacker may leverage these issues to execute arbitrary script code in the browser of an unsuspecting user in the context of the affected site. This may let the attacker steal cookie-based authentication credentials and launch other attacks.
Dolphin 7.0.4 is vulnerable; other versions may also be affected.
Dolphin is prone to multiple cross-site scripting vulnerabilities because it fails to properly sanitize user-supplied input.
An attacker may leverage these issues to execute arbitrary script code in the browser of an unsuspecting user in the context of the affected site. This may let the attacker steal cookie-based authentication credentials and launch other attacks.
Dolphin 7.0.4 is vulnerable; other versions may also be affected.
Exploit / POC
Dolphin Multiple Cross Site Scripting Vulnerabilities
Attackers can exploit these issues by enticing an unsuspecting victim to follow a malicious URI.
The following example URIs are available:
Attackers can exploit these issues by enticing an unsuspecting victim to follow a malicious URI.
The following example URIs are available:
Solution / Fix
Dolphin Multiple Cross Site Scripting Vulnerabilities
Solution:
Currently, we are not aware of any vendor-supplied patches. If you feel we are in error or if you are aware of more recent information, please mail us at: [email protected].
Solution:
Currently, we are not aware of any vendor-supplied patches. If you feel we are in error or if you are aware of more recent information, please mail us at: [email protected].